Physician profile

Chereka Kluttz

Family Medicine · Bradenton, FL

NPI 1053691279

$1,867.40

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$355.21

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Organogenesis INC. $1,104.30 2021-2023 Puraply
Integra Lifesciences Corporation $192.83 2021-2022
Acera Surgical, INC. $181.38 2022
Hydrofera LLC $151.96 2022-2023 Hydrofera Blue
Smith+Nephew, INC. $133.47 2023-2024 Grafix Pl, Renasys Go V2 Home, Collagenase Santyl
Kerecis Limited $62.96 2021
Aroa Biosurgery Incorporated $20.90 2022
Bioventus LLC $19.60 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Chereka Kluttz

$1,867.40

in general payments reported 2019-2025

Years
2021-2024
Top company
Organogenesis INC.

https://glasscript.com/doctor/2414/chereka-kluttz

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.